Literature DB >> 125011

The in vivo inhibition of tumor growth by ruthenium red: its relationship with the metabolism of calcium in the tumor.

L J Anghileri.   

Abstract

Ruthenium red shows antitumor activity on experimental tumors. This growth inhibition seems to be related with the impairment of Ca-2+ transport both at the mitochondrial and at the cell membrane level. A sex influence modifying this inhibition and the systemic effects has been observed.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 125011     DOI： 10.1007/bf00304090

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN： 0084-5353


  9 in total

1.  Phosphorus compounds in animal tissues; the nucleic acid content of homologous normal and cancer tissues.

Authors:  W C SCHNEIDER
Journal:  Cancer Res       Date:  1945-12       Impact factor: 12.701

2.  Radioactive ruthenium red accumulation by tumors: a potential scanning agent.

Authors:  L J Anghileri
Journal:  Strahlentherapie       Date:  1975-02

3.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

4.  Specific inhibition of mitochondrial Ca++ transport by ruthenium red.

Authors:  C L Moore
Journal:  Biochem Biophys Res Commun       Date:  1971-01-22       Impact factor: 3.575

5.  The successful regression of large solid sarcoma 180 tumors by platinum compounds.

Authors:  B Rosenberg; L VanCamp
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

6.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

7.  Calcium, magnesium and phosphorus in experimental tumors: effects of the age of the tumor.

Authors:  L J Anghileri
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

8.  Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium.

Authors:  M M Hart; R H Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

9.  Calcium metabolism in tumors : its relationship with chromium complex accumulation. I. Uptake of calcium and phophorus by experimental tumors.

Authors:  L J Anghileri; E S Miller
Journal:  Oncology       Date:  1971       Impact factor: 2.935
  9 in total
  5 in total

Review 1.  Progress in understanding mitochondrial calcium uniporter complex-mediated calcium signalling: A potential target for cancer treatment.

Authors:  Chaochu Cui; Jianbo Yang; Liwu Fu; Mingyong Wang; Xianwei Wang
Journal:  Br J Pharmacol       Date:  2019-04-03       Impact factor: 8.739

Review 2.  Mitochondrial calcium uniporter complex modulation in cancerogenesis.

Authors:  Saverio Marchi; Veronica Angela Maria Vitto; Alberto Danese; Mariusz R Wieckowski; Carlotta Giorgi; Paolo Pinton
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

3.  Ionic titanocene complexes: a new type of antitumor agent.

Authors:  P Köpf-Maier; E Neuse; T Klapötke; H Köpf
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Filamentous growth of Escherichia coli K12 elicited by dimeric, mixed-valence complexes of ruthenium.

Authors:  J F Gibson; R K Poole; M N Hughes; J F Rees
Journal:  Arch Microbiol       Date:  1984-10       Impact factor: 2.552

Review 5.  VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.

Authors:  Andrea Magrì; Simona Reina; Vito De Pinto
Journal:  Front Chem       Date:  2018-04-06       Impact factor: 5.221
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.